SBCNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as SBCWW
SBC Medical Group Holdings Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$5.36+0.20 (+3.88%)
Close on Oct 19, 2026
- Market cap
- $549.81M
- P/E (TTM)
- 11.4
- Dividend yield
- –
SBC Medical Group statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Offices & Clinics of Doctors of Medicine companies for comparison
Valuation
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Market Cap | $551.26M | $1.11B |
| Enterprise Value | $382.92M | $1.41B |
| PE Ratio | 11.40 | 22.72 |
| PS Ratio | 3.15 | 1.60 |
| PB Ratio | 2.09 | 3.03 |
| P/TBV Ratio | 2.72 | 4.99 |
| P/FCF Ratio | 8.92 | 20.54 |
| P/OCF Ratio | 8.78 | 15.44 |
Enterprise value
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| EV / Sales | 2.19 | 1.69 |
| EV / EBITDA | 5.58 | 14.40 |
| EV / EBIT | 5.85 | 19.04 |
| EV / FCF | 6.20 | 23.16 |
Income (trailing twelve months)
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Revenue | $175.17M | $561.90M |
| Gross Profit | $125.86M | $173.32M |
| Operating Income | $65.41M | -$1.81M |
| Pretax Income | $75.49M | -$572.42K |
| Net Income | $49.03M | -$1.16M |
| EBITDA | $68.63M | -$20.72K |
| EPS (Diluted) | $0.47 | -$0.02 |
Margins
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Gross Margin | 71.9% | 33.1% |
| Operating Margin | 37.3% | -4.45% |
| Pretax Margin | 43.1% | 1.54% |
| Profit Margin | 28.0% | -2.91% |
| EBITDA Margin | 39.2% | 2.41% |
| FCF Margin | 35.3% | 3.13% |
Returns
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Return on Equity (ROE) | 19.3% | 1.84% |
| Return on Assets (ROA) | 13.6% | -3.06% |
| Return on Invested Capital (ROIC) | 50.7% | 2.11% |
| Return on Capital Employed (ROCE) | 19.9% | -0.57% |
Growth
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -6.92% | 6.92% |
| Net Income Growth (YoY) | 47.1% | 19.6% |
| EPS Growth (YoY) | 46.9% | 25.8% |
Balance sheet
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $184.62M | $48.71M |
| Total Debt | $203.51K | $140.00M |
| Net Cash (Debt) | $184.42M | $205.49K |
| Net Cash Per Share | $1.79 | $0.01 |
| Equity (Book Value) | $263.84M | $235.16M |
| Book Value Per Share | $2.57 | $3.48 |
| Tangible Book Value | $202.97M | $703.69K |
| Working Capital | $180.93M | $30.48M |
Financial position
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Current Ratio | 3.31 | 1.40 |
| Quick Ratio | 2.35 | 1.02 |
| Debt / Equity | 0.00 | 0.66 |
| Debt / EBITDA | 0.00 | 2.61 |
| Debt / FCF | 0.00 | 4.59 |
| Net Debt / EBITDA | -2.69 | 2.15 |
| Interest Coverage | 194.92 | -0.63 |
Cash flow (trailing twelve months)
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Operating Cash Flow | $62.82M | $3.10M |
| Capital Expenditures | -$1.05M | -$18.62M |
| Free Cash Flow | $61.77M | $23.73M |
| FCF Per Share | $0.60 | $0.37 |
Efficiency
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Asset Turnover | 0.49 | 0.87 |
| Inventory Turnover | 21.05 | 11.67 |
| Revenue Per Employee | $202.98K | $228.48K |
| Profits Per Employee | $56.81K | -$5.75K |
| Employee Count | 863 | 910 |
Dividends and yields
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Earnings Yield | 8.89% | -0.59% |
| FCF Yield | 11.2% | 1.74% |
Shares
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Shares Outstanding | 102,847,000 | 58,282,400 |
| Shares Change (YoY) | 1.42% | 2.68% |
| Shares Change (QoQ) | 0.00% | 0.32% |
| Float | 18,542,500 | 33,780,100 |
| Shares Held by Insiders | 82.0% | 16.4% |
| Shares Held by Institutions | 8.32% | 85.9% |
Taxes
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Income Tax | $25.31M | $697.00K |
| Effective Tax Rate | 33.5% | 23.1% |
Scores
| Measure | SBC Medical Group | Industry median |
|---|---|---|
| Graham Number | $5.21 | $19.59 |
| Graham Upside | -2.83% | -47.5% |
| Altman Z-Score | 5.01 | 2.05 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from SBC Medical Group's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.